GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LBX Pharmacy Chain JSC (SHSE:603883) » Definitions » EBIT

LBX Pharmacy Chain JSC (SHSE:603883) EBIT : ¥1,527 Mil (TTM As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is LBX Pharmacy Chain JSC EBIT?

LBX Pharmacy Chain JSC's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ¥257 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1,527 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. LBX Pharmacy Chain JSC's annualized ROC % for the quarter that ended in Sep. 2024 was 5.05%. LBX Pharmacy Chain JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 23.04%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. LBX Pharmacy Chain JSC's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 8.37%.


LBX Pharmacy Chain JSC EBIT Historical Data

The historical data trend for LBX Pharmacy Chain JSC's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBX Pharmacy Chain JSC EBIT Chart

LBX Pharmacy Chain JSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 828.33 1,015.35 1,154.12 1,439.75 1,593.44

LBX Pharmacy Chain JSC Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 295.81 442.74 502.71 324.78 256.65

Competitive Comparison of LBX Pharmacy Chain JSC's EBIT

For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBX Pharmacy Chain JSC's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LBX Pharmacy Chain JSC's EV-to-EBIT falls into.


;
;

LBX Pharmacy Chain JSC EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,527 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LBX Pharmacy Chain JSC  (SHSE:603883) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

LBX Pharmacy Chain JSC's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=1036.852 * ( 1 - 25.83% )/( (14940.402 + 15502.443)/ 2 )
=769.0331284/15221.4225
=5.05 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=21029.704 - 7595.425 - ( 1937.434 - max(0, 10146.459 - 8640.336+1937.434))
=14940.402

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=21211.312 - 7251.931 - ( 2100.506 - max(0, 10149.647 - 8606.585+2100.506))
=15502.443

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

LBX Pharmacy Chain JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1026.588/( ( (4381.429 + max(-1471.003, 0)) + (4531.129 + max(-1398.49, 0)) )/ 2 )
=1026.588/( ( 4381.429 + 4531.129 )/ 2 )
=1026.588/4456.279
=23.04 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2032.093 + 3957.619 + 396.026) - (7595.425 + 0 + 261.316)
=-1471.003

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2000.734 + 3741.314 + 402.196) - (7251.931 + 0 + 290.803)
=-1398.49

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

LBX Pharmacy Chain JSC's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=1526.881/18233.288
=8.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LBX Pharmacy Chain JSC EBIT Related Terms

Thank you for viewing the detailed overview of LBX Pharmacy Chain JSC's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


LBX Pharmacy Chain JSC Business Description

Traded in Other Exchanges
N/A
Address
No. 288, Xiangya Road, Kaifu District, Hunan, Changsha, CHN, 410005
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.

LBX Pharmacy Chain JSC Headlines

No Headlines